CD44 and experimental autoimmune encephalomyelitis: Under pathological conditions such as multiple sclerosis (MS) and its respective experimental model in rodents (Experimental Autoimmune Encephalomyelitis, EAE), CD44 has immunomodulatory properties and protects from the disruption of the BBB [43].